AAAAAA

   
Results: 1-8 |
Results: 8
A phase II trial of dual protease inhibitor therapy: Amprenavir in combination with indinavir, nelfinavir, or saquinavir
Authors: Eron, JJ Haubrich, R Lang, W Pagano, G Millard, J Wolfram, J Snowden, W Pedneault, L Tisdale, M
Citation: Jj. Eron et al., A phase II trial of dual protease inhibitor therapy: Amprenavir in combination with indinavir, nelfinavir, or saquinavir, J ACQ IMM D, 26(5), 2001, pp. 458-461
Metabolic complications associated with antiretroviral therapy
Authors: Jain, RG Furfine, ES Pedneault, L White, AJ Lenhard, JM
Citation: Rg. Jain et al., Metabolic complications associated with antiretroviral therapy, ANTIVIR RES, 51(3), 2001, pp. 151-177
Safety profile and tolerability of amprenavir in patients enrolled in an early access program
Authors: Scott, T Garris, C Rogers, M Graham, N Garrett, L Pedneault, L
Citation: T. Scott et al., Safety profile and tolerability of amprenavir in patients enrolled in an early access program, CLIN THER, 23(2), 2001, pp. 252-259
Recurrent cleft lip and palate in siblings of a patient with malabsorptionsyndrome, probably caused by hypovitaminosis A associated with folic acid and vitamin B-2 deficiencies
Authors: Faron, G Drouin, R Pedneault, L Poulin, LD Laframboise, R Garrido-Russo, M Fraser, WD
Citation: G. Faron et al., Recurrent cleft lip and palate in siblings of a patient with malabsorptionsyndrome, probably caused by hypovitaminosis A associated with folic acid and vitamin B-2 deficiencies, TERATOLOGY, 63(3), 2001, pp. 161-163
Amprenavir in combination with lamivudine and zidovudine versus lamivudineand zidovudine alone in HIV-1-infected antiretroviral-naive adults
Authors: Goodgame, JC Pottage, JC Jablonowski, H Hardy, WD Stein, A Fischl, M Morrow, P Feinberg, J Brothers, CH Vafidis, I Nacci, P Yeo, J Pedneault, L
Citation: Jc. Goodgame et al., Amprenavir in combination with lamivudine and zidovudine versus lamivudineand zidovudine alone in HIV-1-infected antiretroviral-naive adults, ANTIVIR TH, 5(3), 2000, pp. 215-225
Antiretroviral resistance testing comes of age
Authors: Hammer, SM Pedneault, L
Citation: Sm. Hammer et L. Pedneault, Antiretroviral resistance testing comes of age, ANTIVIR TH, 5(1), 2000, pp. 23-26
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan
Authors: DeGruttola, V Dix, L D'Aquila, R Holder, D Phillips, A Ait-Khaled, M Baxter, J Clevenbergh, P Hammer, S Harrigan, R Katzenstein, D Lanier, R Miller, M Para, M Yerly, S Zolopa, A Murray, J Patick, A Miller, V Castillo, S Pedneault, L Mellors, J
Citation: V. Degruttola et al., The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan, ANTIVIR TH, 5(1), 2000, pp. 41-48
Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection
Authors: Pedneault, L Brothers, C Pagano, G Tymkewycz, P Yeo, J Millard, J Fetter, A
Citation: L. Pedneault et al., Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection, CLIN THER, 22(12), 2000, pp. 1378-1394
Risultati: 1-8 |